We are live on ! Find out more
ARTA

A.R.T. Advisors Portfolio holdings

AUM $1.79M
1-Year Est. Return 57.47%
This Fund
S&P 500
This Quarter Est. Return
+27.4%
1 Year Est. Return
+57.47%
3 Year Est. Return
+81.79%
5 Year Est. Return
+178.88%
10 Year Est. Return
–
AUM
$21.6M
AUM Growth
+$3.9M
Cap. Flow
+$1.75M
Cap. Flow %
8.1%
Top 10 Hldgs %
30.06%
Holding
126
New
58
Increased
4
Reduced
8
Closed
54

Top Buys

Rank Stock Value
1
REGN icon
Regeneron Pharmaceuticals
REGN
+$809K
2
MRK icon
Merck
MRK
+$736K
3
XOM icon
ExxonMobil
XOM
+$731K
4
VRTX icon
Vertex Pharmaceuticals
VRTX
+$648K
5
UAL icon
United Airlines
UAL
+$623K

Top Sells

Rank Stock Value
1
JNJ icon
Johnson & Johnson
JNJ
+$1.61M
2
BMY icon
Bristol-Myers Squibb
BMY
+$1.04M
3
DAL icon
Delta Air Lines
DAL
+$846K
4
ALXN
Alexion Pharmaceuticals
ALXN
+$501K
5
COST icon
Costco
COST
+$395K

Sector Composition

Rank Sector Weight
1 Healthcare 32.61%
2 Consumer Discretionary 11.06%
3 Industrials 10.97%
4 Energy 10.3%
5 Technology 9.53%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
WLL
126
DELISTED
Whiting Petroleum Corporation
WLL
– –
-15,714
Closed -$272K
2 3 4 5
6

Similar funds

MA
MANA Advisors New York $3.06M AUM 7.13% 1-Year Est. Return
FFIM
Founders Fund III Management San Francisco, California $435K AUM
LC
Lunia Capital Dallas, Texas $4.49M AUM 42.82% 1-Year Est. Return
YEPV
Yorktown Energy Partners VI New York $6.21M AUM 74.4% 1-Year Est. Return
AAM
Areion Asset Management Hong Kong $7.82M AUM 16% 1-Year Est. Return
CCM
Copernicus Capital Management San Francisco, California $8.26M AUM 37.91% 1-Year Est. Return
IR
Invictus RG Hamilton, Bermuda $8.9M AUM 56.32% 1-Year Est. Return
IFC
Intact Financial Corporation Toronto, Ontario, Canada $14M AUM

A.R.T. Advisors's Q4 2020 Portfolio in Review

As of Q4 2020, A.R.T. Advisors held 126 positions worth $21.6M, up 22% from $17.7M the previous quarter. Its ten largest holdings account for 30% of the portfolio.

A.R.T. Advisors deployed $1.75M of net new capital in Q4 2020, opening 58 new positions and adding to 4 existing holdings. Its largest new stake was Regeneron Pharmaceuticals: 1,498 shares worth $724K.

By sector, the portfolio is most concentrated in Healthcare at 33% of assets, up from 29% a quarter earlier, followed by Consumer Discretionary and Industrials.

On the sell side, the largest reduction was Johnson & Johnson, an estimated $1.61M trimmed.

  • A.R.T. Advisors's largest Q4 2020 buy was Regeneron Pharmaceuticals: 1,498 shares worth $724K.
  • A.R.T. Advisors added most to Ford in Q4 2020, an estimated $80.4K increase.
  • A.R.T. Advisors's biggest Q4 2020 reduction was Johnson & Johnson, cutting an estimated $1.61M.
  • A.R.T. Advisors fully exited Bristol-Myers Squibb in Q4 2020, selling an estimated $1.04M.
  • A.R.T. Advisors's ten largest holdings make up 30% of its $21.6M portfolio in Q4 2020.
  • A.R.T. Advisors opened 58 new positions and closed 54 in Q4 2020.
  • A.R.T. Advisors's portfolio value rose 22% quarter-over-quarter to $21.6M.

Based on A.R.T. Advisors's 13F filing for Q4 2020, filed 16 Feb 2021.